BXA0 Stock Chart & Stats
€1.27
>-€0.01(-0.80%)
At close: 4:00 PM EST
€1.27
>-€0.01(-0.80%)
Day’s Range― - ―
52-Week Range€0.71 - €1.85
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€267.44M
Enterprise Value€157.29
Total Cash (Recent Filing)€5.59M
Total Debt (Recent Filing)€28.14M
Price to Earnings (P/E)44.8
Beta0.49
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.28%
Share Statistics
EPS (TTM)N/A
Shares Outstanding170,778,490
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BXA0 FAQ
What was Lavipharm S.A.’s price range in the past 12 months?
Lavipharm S.A. lowest stock price was €0.71 and its highest was €1.85 in the past 12 months.
What is Lavipharm S.A.’s market cap?
Lavipharm S.A.’s market cap is €267.44M.
When is Lavipharm S.A.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Lavipharm S.A.’s earnings last quarter?
Currently, no data Available
Is Lavipharm S.A. overvalued?
According to Wall Street analysts Lavipharm S.A.’s price is currently Overvalued.
Does Lavipharm S.A. pay dividends?
Lavipharm S.A. pays a N/A dividend of €0.019 which represents an annual dividend yield of 1.28%. See more information on Lavipharm S.A. dividends here
What is Lavipharm S.A.’s EPS estimate?
Lavipharm S.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lavipharm S.A. have?
Lavipharm S.A. has 170,778,490 shares outstanding.
What happened to Lavipharm S.A.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Lavipharm S.A.?
Currently, no hedge funds are holding shares in DE:BXA0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lavipharm S.A.
Lavipharm S.A. is a company that specializes in the comprehensive lifecycle of pharmaceutical, dermocosmetic, and general healthcare products, from initial research and development to manufacturing, importation, marketing, and distribution. Its operations span both the Greek domestic market and international territories. The company's diverse pharmaceutical offerings cater to numerous therapeutic areas, including cardiology, chronic pain management, oncology, central nervous system disorders, general medicine, gastrointestinal health, and urology. In addition to prescription medications, Lavipharm provides a range of over-the-counter (OTC) drugs such as antiseptics, analgesics, and anti-lice treatments, alongside various skincare solutions. This enterprise, headquartered in Paiania, Greece, was established in 1911.